Cargando…
Involvement of Akt/mTOR in the Neurotoxicity of Rotenone-Induced Parkinson’s Disease Models
Rotenone has recently been widely used to establish Parkinson’s disease (PD) models to replicate the features of PD. However, the mechanisms involved in rotenone neurotoxicity have not been elucidated. The aim of the present study was to identify the neurotoxicity of rotenone through intraperitoneal...
Autores principales: | , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6843606/ https://www.ncbi.nlm.nih.gov/pubmed/31658620 http://dx.doi.org/10.3390/ijerph16203811 |
_version_ | 1783468255385485312 |
---|---|
author | Zhang, Yu Guo, Hui Guo, Xinyu Ge, Denfeng Shi, Yue Lu, Xiyu Lu, Jinli Chen, Juan Ding, Fei Zhang, Qi |
author_facet | Zhang, Yu Guo, Hui Guo, Xinyu Ge, Denfeng Shi, Yue Lu, Xiyu Lu, Jinli Chen, Juan Ding, Fei Zhang, Qi |
author_sort | Zhang, Yu |
collection | PubMed |
description | Rotenone has recently been widely used to establish Parkinson’s disease (PD) models to replicate the features of PD. However, the mechanisms involved in rotenone neurotoxicity have not been elucidated. The aim of the present study was to identify the neurotoxicity of rotenone through intraperitoneal injection in mice and to investigate the global changes of phosphorylation proteomic profiles in rotenone-injured SH-SY5Y cells through a label-free proteomic analysis using a PTMScan with LC–MS/MS. ICR (Institute of Cancer Research) mice were intraperitoneally injected with different dosages of rotenone (1 mg/kg/d or 3 mg/kg/d) daily for 21 consecutive days. Rotenone caused a dose-dependent decrease in locomotor activities and a decrease in the number of Nissl-positive and tyrosine hydroxylase (TH)-immunoreactive neurons in the substantia nigra pars compacta (SNpc). Here, 194 phosphopeptides on 174 proteins were detected in SH-SY5Y cells, and 37 phosphosites on 33 proteins displayed statistically significant changes in expression after rotenone injury. The downregulation of phosphorylated Akt and mTOR was further confirmed by western blot analysis. A specific Akt activator, SC79, could protect cell viability and induce autophagy in rotenone-injured SH-SY5Y cells. This study indicates the involvement of the Akt/mTOR (mammalian target of rapamycin) signaling pathway in rotenone-injured SH-SY5Y cells and provides molecular information for the neurotoxicity of rotenone. |
format | Online Article Text |
id | pubmed-6843606 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2019 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-68436062019-11-25 Involvement of Akt/mTOR in the Neurotoxicity of Rotenone-Induced Parkinson’s Disease Models Zhang, Yu Guo, Hui Guo, Xinyu Ge, Denfeng Shi, Yue Lu, Xiyu Lu, Jinli Chen, Juan Ding, Fei Zhang, Qi Int J Environ Res Public Health Article Rotenone has recently been widely used to establish Parkinson’s disease (PD) models to replicate the features of PD. However, the mechanisms involved in rotenone neurotoxicity have not been elucidated. The aim of the present study was to identify the neurotoxicity of rotenone through intraperitoneal injection in mice and to investigate the global changes of phosphorylation proteomic profiles in rotenone-injured SH-SY5Y cells through a label-free proteomic analysis using a PTMScan with LC–MS/MS. ICR (Institute of Cancer Research) mice were intraperitoneally injected with different dosages of rotenone (1 mg/kg/d or 3 mg/kg/d) daily for 21 consecutive days. Rotenone caused a dose-dependent decrease in locomotor activities and a decrease in the number of Nissl-positive and tyrosine hydroxylase (TH)-immunoreactive neurons in the substantia nigra pars compacta (SNpc). Here, 194 phosphopeptides on 174 proteins were detected in SH-SY5Y cells, and 37 phosphosites on 33 proteins displayed statistically significant changes in expression after rotenone injury. The downregulation of phosphorylated Akt and mTOR was further confirmed by western blot analysis. A specific Akt activator, SC79, could protect cell viability and induce autophagy in rotenone-injured SH-SY5Y cells. This study indicates the involvement of the Akt/mTOR (mammalian target of rapamycin) signaling pathway in rotenone-injured SH-SY5Y cells and provides molecular information for the neurotoxicity of rotenone. MDPI 2019-10-10 2019-10 /pmc/articles/PMC6843606/ /pubmed/31658620 http://dx.doi.org/10.3390/ijerph16203811 Text en © 2019 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Zhang, Yu Guo, Hui Guo, Xinyu Ge, Denfeng Shi, Yue Lu, Xiyu Lu, Jinli Chen, Juan Ding, Fei Zhang, Qi Involvement of Akt/mTOR in the Neurotoxicity of Rotenone-Induced Parkinson’s Disease Models |
title | Involvement of Akt/mTOR in the Neurotoxicity of Rotenone-Induced Parkinson’s Disease Models |
title_full | Involvement of Akt/mTOR in the Neurotoxicity of Rotenone-Induced Parkinson’s Disease Models |
title_fullStr | Involvement of Akt/mTOR in the Neurotoxicity of Rotenone-Induced Parkinson’s Disease Models |
title_full_unstemmed | Involvement of Akt/mTOR in the Neurotoxicity of Rotenone-Induced Parkinson’s Disease Models |
title_short | Involvement of Akt/mTOR in the Neurotoxicity of Rotenone-Induced Parkinson’s Disease Models |
title_sort | involvement of akt/mtor in the neurotoxicity of rotenone-induced parkinson’s disease models |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6843606/ https://www.ncbi.nlm.nih.gov/pubmed/31658620 http://dx.doi.org/10.3390/ijerph16203811 |
work_keys_str_mv | AT zhangyu involvementofaktmtorintheneurotoxicityofrotenoneinducedparkinsonsdiseasemodels AT guohui involvementofaktmtorintheneurotoxicityofrotenoneinducedparkinsonsdiseasemodels AT guoxinyu involvementofaktmtorintheneurotoxicityofrotenoneinducedparkinsonsdiseasemodels AT gedenfeng involvementofaktmtorintheneurotoxicityofrotenoneinducedparkinsonsdiseasemodels AT shiyue involvementofaktmtorintheneurotoxicityofrotenoneinducedparkinsonsdiseasemodels AT luxiyu involvementofaktmtorintheneurotoxicityofrotenoneinducedparkinsonsdiseasemodels AT lujinli involvementofaktmtorintheneurotoxicityofrotenoneinducedparkinsonsdiseasemodels AT chenjuan involvementofaktmtorintheneurotoxicityofrotenoneinducedparkinsonsdiseasemodels AT dingfei involvementofaktmtorintheneurotoxicityofrotenoneinducedparkinsonsdiseasemodels AT zhangqi involvementofaktmtorintheneurotoxicityofrotenoneinducedparkinsonsdiseasemodels |